Skip to content

This Site is Intended for Healthcare Professionals Only

Search AI Powered

Latest Stories

Alex Potter is new MD at PharmAssist Solutions UK

Alex Potter is the new Managing Director of PharmAssist Solutions UK, an online purchasing solution utilised by over 1,100 community pharmacies. Potter, previously the Director of Digital at Phoenix UK, will succeed the current MD, Amar Randhawa, and has expertise in the digital landscape across the industry, PharmAssist Solutions said in a statement.

"We are delighted to have Alex on board," said Stuart Lucas, Chair of the PharmAssist Solutions Board. "His profound grasp of the pharmacy sector, combined with his expertise in digital innovation, will spearhead PharmAssist Solution's evolution to meet the dynamic demands of its clientele."


Meanwhile, Lucas expressed his gratitude and appreciation to Amar for his hard work and dedication over the last decade. "Amar, as the founder of PharmAssist Solutions, played a pivotal role in achieving numerous significant milestones and driving its growth," he added. "We wish him every success in his future endeavors."

"Alex’s profound expertise in the digital realm will undoubtedly propel PharmAssist Solutions to new heights," added Jeremy Main, Independent NED for PharmAssist Solutions. "This appointment builds on the impressive legacy left by Amar, fortifying our capacity to deliver a top-tier service in the pharmacy sector."

PharmAssist Solutions is dedicated to furnishing pharmacy teams with state-of-the-art software solutions that foster business development and growth, the statement added.

Last week, Titan PMR, a technology firm specialising in PMR systems for community pharmacies, introduced 'Titanverse'. This platform aims to redefine pharmacy management by offering comprehensive solutions that extend beyond prescription management, and takes a versatile approach, efficiently handling all facets of pharmacy operations, from high-level management down to daily tasks, according to the company.

More For You

Lynsey Cleland named GPhC chief standards officer

Lynsey Cleland

Pic credit: X

Lynsey Cleland named GPhC chief standards officer

The General Pharmaceutical Council (GPhC) has brought back Lynsey Cleland to lead on a number of important departments in the role of chief standards officer.

Cleland had previously held a number of senior positions at GPhC, including director of Scotland.

Keep ReadingShow less
Pharma industry group unhappy with NHS drug pricing offer

The ABPI warned that £2 billion of potential investment could be under risk

Pic credit: istock

Pharma industry group unhappy with NHS drug pricing offer

The Association of the British Pharmaceutical Industry (ABPI) has rejected the UK government’s offer to cut the cost of NHS drugs pricing scheme as it felt it was inadequate.

The industry group warned that £2 billion of potential investment could be under risk and wanted prime minister Keir Starmer to intervene, The Times reports.

Keep ReadingShow less
Day Lewis celebrates 50 years of delivering care to communities

The Patel family at the unveiling of the commemorative plaque ceremony

Day Lewis celebrates 50 years of delivering care to communities

Day Lewis honoured "the people, purpose and partnerships" as it celebrated 50 years of service by unveiling a commemorative plaque at the company’s support office in Croydon.

As one of the UK’s largest independent pharmacy chains, Day Lewis has delivered trusted care to communities across the country since it was founded in 1975, by brothers Kirit and JC Patel, who was on hand to unveil the plaque.

Keep ReadingShow less
CPE said the committee’s discussions are fully shaped by pharmacy owners’ views and experiences

CPE said the committee’s discussions are fully shaped by pharmacy owners’ views and experiences

Pic credit: iStock

Pharmacy owners asked to share views on new contract and its financial implications

Pharmacy owners can share their thoughts on service developments and their financial security before the upcoming Community Pharmacy England (CPE) committee meeting to be held on June 25 and 26.

The new Community Pharmacy Contractual Framework (CPCF) was completed in March with the various service and regulatory changes still in progress.

Keep ReadingShow less
Cancer treatment impact

There have been supply issues with Creon since the summer of 2024

Pic credit: iStock

Cancer patients struggle amid digestive drug shortage

Pharmacists in the Channel Islands have revealed that there is a shortage of a drug used to support digestion in cancer patients.

Creon is a pancreatic enzyme replacement therapy (PERT), which helps people living with conditions such as cystic fibrosis, pancreatitis, and pancreatic cancer to digest food.

Keep ReadingShow less